TuHURA BIOSCIENCES, INC./NV Proceeds from Issuance of Warrants
TuHURA BIOSCIENCES, INC./NV (HURA) reported Proceeds from Issuance of Warrants of $1.49 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2017-09-27
- TuHURA BIOSCIENCES, INC./NV proceeds from issuance of warrants for the quarter ending 2017-06-30 was -$411.22K, a 162.01% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV proceeds from issuance of warrants for the quarter ending 2017-03-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV proceeds from issuance of warrants for the quarter ending 2016-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV proceeds from issuance of warrants for the quarter ending 2016-09-30 was $1.90M, a 25.84% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV proceeds from issuance of warrants for fiscal 2017 was $1.49M, a 41.86% decline from fiscal 2016.
- TuHURA BIOSCIENCES, INC./NV proceeds from issuance of warrants for fiscal 2016 was $2.57M, a 82.79% increase from fiscal 2015.
- TuHURA BIOSCIENCES, INC./NV proceeds from issuance of warrants for fiscal 2015 was $1.40M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2017-06-30 | -$411.22K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | -$411.22K derived: sum of 2 quarters · filed 2017-09-27 | -$411.22K derived: sum of 3 quarters · filed 2017-09-27 | $1.49M 10-K · filed 2017-09-27 | |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-12 | $0.00 derived: sum of 2 quarters · filed 2017-05-12 | $1.90M 10-Q · filed 2017-05-12 | $2.57M derived: sum of 4 quarters · filed 2017-09-27 | |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | $1.90M 10-Q · filed 2017-02-10 | $2.57M derived: sum of 3 quarters · filed 2017-09-27 | $2.57M derived: sum of 4 quarters · filed 2017-09-27 | |
| 2016-09-30 | $1.90M 10-Q · filed 2016-11-10 | $2.57M derived: sum of 2 quarters · filed 2017-09-27 | $2.57M derived: sum of 3 quarters · filed 2017-09-27 | $1.90M derived: sum of 4 quarters · filed 2017-09-27 | |
| 2016-06-30 | $663.15K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | $663.15K derived: sum of 2 quarters · filed 2017-09-27 | $0.00 derived: sum of 3 quarters · filed 2017-09-27 | $2.57M 10-K · filed 2017-09-27 | $1.90M 10-K · filed 2016-09-13 |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -$663.15K derived: sum of 2 quarters · filed 2016-05-12 | $1.90M 10-Q · filed 2016-05-12 | $1.90M derived: sum of 4 quarters · filed 2016-05-12 | |
| 2015-12-31 | -$663.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $1.90M 10-Q · filed 2016-02-12 | $1.90M derived: sum of 3 quarters · filed 2016-02-12 | $2.04M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2015-09-30 | $2.57M 10-Q · filed 2015-11-16 | $2.57M derived: sum of 2 quarters · filed 2015-11-16 | $2.70M derived: sum of 3 quarters · filed 2015-11-16 | ||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-16 | $138.00K derived: sum of 2 quarters · filed 2015-11-16 | $1.40M 10-K · filed 2015-11-16 | ||
| 2015-03-31 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $1.40M 10-Q · filed 2015-05-15 | |||
| 2014-12-31 | $1.27M 10-Q · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |